Filtration in sepsis: Fiction or reality for the clinician?;Épuration dans le sepsis: Fiction ou réalité pour le clinicien?

Reanimation

Volumn 19, Issue 5 SUPPL. 1, 2010, Pages 7-12

  Honore P M ^a   Joannes Boyau, O ^b   Jacobs, R ^a   Solignac, M ^c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACTIVE TRANSPORT; BLOOD FILTRATION; CONFERENCE PAPER; CONTINUOUS RENAL REPLACEMENT THERAPY; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; PURIFICATION; SEPSIS;

EID: 77957792676     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1624-0693(10)70007-4     Document Type: Conference Paper

References (21)

1. P.M. Honoré, O. Joannes-Boyau, W. Boer, and V. Collin High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects Blood Purif 28 2009 1 11
2. J.V. Di Carlo, and S.R. Alexander Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis Int J Artif Organs 28 2005 777 786
3. V. Cantaluppi, V. Weber, C. Lauritano, F. Figliolini, S. Beltramo, and L. Biancone Protective effects of resin adsorption on septic plasma-induced tubular injury Crit Care 14 2010 R4 [Epub ahead of print]
4. J.A. Kellum, M. Song, and R. Venkataraman Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia Crit Care Med 32 2004 801 805
5. P.M. Honoré, O. Joannes-Boyau, V. Collin, W. Boer, and S. Jennes Continuous hemofiltration in 2009: what is new for clinicians regarding pathophysiology, preferred technique and recommended dose? Blood Purif 28 2009 135 143
6. S. Vesconi, D.N. Cruz, R. Fumagalli, D. Kingen-Milles, G. Monti, A. Marinho DO-RE-MI Study Group Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury Crit Care 13 2009 R57
7. J.A. Kellum, L. Kong, M.P. Fink, L.A. Weissfeld, D.M. Yealy, M.R. Pinsky GenIMS Investigators Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med 167 2007 1655 1663
8. K. Reiter, V. d'Intini, V. Bordoni, I. Baldwin, R. Bellomo, and C. Tetta High-volume hemofiltration in sepsis Nephron 92 2002 251 258
9. C. Ronco, R. Bellomo, P. Omel, A. Brendolan, M. Dan, and P. Piccinni Effect of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial Lancet 356 2000 26 30
10. P. Saudan, M. Niederberger, S. de Seigneux, J. Romand, J. Pugon, and T. Perneger Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure Kidney Int 70 2006 1312 1317
11. C. Ronco, S.M. Bagshaw, R.T. Gibney, and R. Bellomo Outcome comparisons of intermittent and continuous therapies in acute kidney injury: what do they mean? Int J Artif Organs 31 2008 213 220 Review
12. H. Schiffl, S.M. Lang, and R. Fischer Daily hemodialysis and the outcome of acute renal failure N Engl J Med 346 2002 305 310 (Pubitemid 34438837)
13. P.M. Palewsky, J.H. Zhang, T.Z. O'Connor, G.M. Chertow, S.T. Crowley, D. Choudury VA/NIH Acute Renal Failure Trial Network Intensity of renal support in critically ill patients with acute kidney injury N Engl J Med 359 2008 7 20
14. C. Ronco, D. Cruz, H. Oudemans van Straaten, P. Honoré, A. House, and D. Bin Dialysis dose in acute kidney injury: no time for therapeutic nihilism - a critical appraisal of the Acute Renal Failure Trial Network study Crit Care 12 2008 308
15. D. Payen, J. Mateo, J.M. Cavaillon, F. Fraisse, C. Floriot, and E. Vicaut Hemofiltration and Sepsis Group of the Collge National de Réanimation et de Médecine d'Urgence des Hôpitaux extra-Universitaires. Impact of continuous veno-venous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial Crit Care Med 37 2009 803 810
16. R. Bellomo, A. Cass, L. Cole, S. Finfer, M. Gallagher, S. Lo RENAL replacement Therapy Study Investigators Intensity of continuous renal-replacement therapy in critically ill patients N Engl J Med 361 2009 1627 1638
17. S. Morgera, M. Haase, T. Kuss, O. Vargas-Hein, H. Zuckermann-Becker, and C. Melzer Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure Crit Care Med 34 2006 2099 2104
18. P.M. Honore Novel Therapeutical Concepts for Extracorporeal Treatment of Hyperinflammation and Sepsis: Immunomodulation Approach with A Novel High Cut-OFF Membrane: The SepteX Membrane Proceedings of 10th Congress of World Federation of CCU (WFSICCM) Florence,30 th August, Italy 2009
19. S. Uchino, R. Bellomo, D. Goldsmith, P. Davenport, L. Cole, and I. Baldwin Super high flux hemofiltration: a new technique for cytokine removal Intensive Care Med 28 2002 651 655
20. D.N. Cruz, M. Antonelli, R. Fumagalli, F. Foltran, N. Brienza, and A. Donati Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial JAMA 301 2009 2445 2452
21. Joannes-Boyau O, Honore PM: The IVOIRE study. Available at: www.clinicaltrialsgow/ct/show/NCT00241228. Accessed March 2010.